文献速递前列腺癌

PI-RADS v2 检测临床显著前列腺癌的前瞻性准确性研究:以全mount病理为参照

A Prospective Accuracy Study of Prostate Imaging Reporting and Data System Version 2 on Multiparametric Magnetic Resonance Imaging in Detecting Clinically Significant Prostate Cancer With Whole-mount Pathology.
PubMed 文献 · Urology · 2018-09-28

病灶分析中,PI-RADS v2阈值≥3的敏感度为0.75和0.67,假发现率为0.17和0.13;阈值≥4时敏感度略低但假发现率近半。患者分析中阈值≥3的敏感度为0.85和0.78。读者间一致性为中等至高度(k 0.72和0.65)。

要点

  • PI-RADS v2阈值≥3检测csPCa的病灶敏感度为0.75/0.67,患者敏感度为0.85/0.78。
  • 阈值≥4时假发现率较≥3近半,但敏感度略降。
  • 两名有经验读者间一致性为中等至高度(k 0.72和0.65)。

核心结论

  • 以根治性前列腺切除术后全mount病理为参照,PI-RADS v2检测csPCa具有良好敏感度,两名有经验读者间一致性为中等至高度。
  • 阈值≥4时假发现率较≥3近半。

研究设计与样本

  • 两名有经验放射科医生按PI-RADS v2独立评分并映射病灶,一名有经验泌尿病理医生按PI-RADS v2分区方案映射全mount病理癌灶。
  • 进行病灶分析和患者分析,主要结局为阈值≥3和≥4检测csPCa的敏感度和假发现率,次要结局为读者间一致性。

主要发现

  • 病灶分析中,阈值≥3的敏感度和假发现率分别为读者1:0.75和0.17,读者2:0.67和0.13。
  • 阈值≥4时敏感度略低,假发现率近半。
  • 患者分析中,阈值≥3检测csPCa的敏感度为读者1:0.85,读者2:0.78;阈值≥4时敏感度略低。
  • 读者间一致性为中等至高度(阈值≥3和≥4的k分别为0.72和0.65)。

临床怎么用

  • 在根治性前列腺切除术前评估中,PI-RADS v2阈值≥3可提供较高敏感度检测csPCa。
  • 采用阈值≥4可降低假发现率,但敏感度略降。

局限性

  • 仅纳入根治性前列腺切除术前患者,存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the accuracy of Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) in detecting clinically significant prostate cancer (csPCa) on multiparametric magnetic resonance imaging (mpMRI) using whole-mount sections after radical prostatectomy (RP) as reference standard. METHODS: Forty-eight patients undergoing mpMRI before RP were prospectively enrolled. Two experienced radiologists independently scored and mapped imaging findings according to PI-RADS v2. One experienced uropathologist mapped cancers detected on whole-mount sections using the PI-RADS v2 sector scheme. Per-lesion and per-patient analyses were run. Primary outcomes were sensitivity and false discovery rate (FDR) in detecting csPCa using PI-RADS v2 score ≥3 and ≥4 as thresholds. Secondary outcome was inter-reader agreement. RESULTS: On the per-lesion analysis, sensitivity and FDR at the PI-RADS v2 threshold score ≥3 were 0.75 and 0.17 for Reader 1, and 0.67 and 0.13 for Reader 2, respectively. At the PI-RADS v2 threshold score ≥4, sensitivity was slightly lower, and FDR nearly halved for both readers. On the per-patient analysis, sensitivity for csPCa at the PI-RADS v2 threshold score ≥3 was 0.85 for Reader 1, and 0.78 for Reader 2. At the PI-RADS v2 threshold score ≥4, sensitivity was slightly lower for both readers. Inter-reader agreement was substantial (k 0.72 and 0.65 for PI-RADS v2 threshold score ≥3 and ≥4, respectively). CONCLUSION: In our prospective study with pathology after RP as standard of reference, PI-RADS v2 showed good sensitivity in detecting csPCa on mpMRI with substantial agreement between 2 experienced readers. Threshold score ≥4 had lower FDR.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Giannarini G, Girometti R, Crestani A, et al. A Prospective Accuracy Study of Prostate Imaging Reporting and Data System Version 2 on Multiparametric Magnetic Resonance Imaging in Detecting Clinically Significant Prostate Cancer With Whole-mount Pathology. Urology. 2018. PMID: 30273613. doi:10.1016/j.urology.2018.07.067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。